Dafna Capital Management LLC Aslan Pharmaceuticals LTD Transaction History

Dafna Capital Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$0.36 - $0.9 $36,000 - $90,000	100,000 Added 41.03%	343,720 $170,000
Q1 2022 May 16, 2022	SELL	$0.74 - $1.22 $361,697 - $596,311	-488,780 Reduced 66.73%	243,720 $219,000
Q3 2021 Nov 15, 2021	BUY	$1.78 - $3.41 $97,900 - $187,550	55,000 Added 8.12%	732,500 $1.3 Million
Q1 2021 May 17, 2021	BUY	$1.86 - $5.25 $1.26 Million - $3.56 Million	677,500 New	677,500 $2.27 Million
Q4 2020 Feb 16, 2021	SELL	$1.54 - $2.22 $132,566 - $191,102	-86,082 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$0.93 - $2.8 $29,388 - $88,480	-31,600 Reduced 26.85%	86,082 $88,000
Q4 2019 Feb 14, 2020	BUY	$0.37 - $5.2 $43,542 - $611,946	117,682 New	117,682 $239,000

Ticker ASLN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,744,704
Market Cap $41.8M
Description
ASLAN Pharmaceuticals Limited, a clinical-stage immunology focused biopharmaceutical company, engages in developing various treatments to transform the lives of patients. The company's clinical portfolio comprises ASLAN004, a monoclonal therapy that is being developed in atopic dermatitis and other immunology indications; and ASLAN003, a small-m...

Get notified when there are updates to the investment portfolio of Dafna Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Dafna Capital Management LLC with notifications on news.